Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "Primary hyperoxaluria type 3"
Show Display Options
Rank Status Study
1 Active, not recruiting PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)
Condition: Newly Diagnosed, Previously Untreated Multiple Myeloma
Interventions: Drug: Lenalidomide;   Drug: Dexamethasone;   Biological: Elotuzumab
2 Completed Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Gemcitabine;   Drug: Docetaxel
3 Completed Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
Condition: Asthma
Intervention: Drug: Omalizumab
4 Recruiting Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Pancreatic Intraductal Papillary-Mucinous Neoplasm;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Capecitabine;   Drug: Chemotherapy;   Drug: Erlotinib Hydrochloride;   Drug: Fluorouracil;   Drug: Gemcitabine Hydrochloride;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
5 Completed
Has Results
First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: Carboplatin;   Drug: Paclitaxel
6 Recruiting Rare Kidney Stone Consortium Biobank
Conditions: Primary Hyperoxaluria;   Dent Disease;   APRT Deficiency;   Cystinuria

Indicates status has not been verified in more than two years